ABEONA THERAPEUTICS INC. 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Our common stock has traded on the Nasdaq Capital Market (“Nasdaq”) under the symbol “ABEO” since June 22, 2015. We have never declared or paid any cash dividends on our common stock and we do not anticipate paying any cash dividends on our common stock in the foreseeable future. The payment of dividends, if any, in the future is within the discretion of our Board of Directors and will depend on our earnings, capital requirements and financial condition and other relevant facts. We currently intend to retain all future earnings, if any, to finance the development and growth of our business. The number of record holders of our common stock as of March 21, 2022 was approximately 166. Equity Compensation Plan Information The following table sets forth, as of December 31, 2021, information about shares of common stock outstanding and available for issuance under our existing equity compensation plans. Plan Category Number of securities to be issued upon exercise of outstanding options, warrants and rights Weighted-average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (a) (b) (c) Equity compensation plans approved by security holders: 2015 Equity Incentive Plan 7,854,851 $ 1.54 1,388,108 2005 Equity Incentive Plan 80,000 1.28 - Equity compensation plans not approved by security holders - - - Total 7,934,851 $ 1.54 1,388,108 Issuer Repurchases of Equity Securities None. Recent Sales of Unregistered Securities None. 64 ITEM 6. [RESERVED]